162 related articles for article (PubMed ID: 20306031)
1. Alpha particles more promising than toxins?
Barbet J; Chérel M; Chatal JF
Eur J Nucl Med Mol Imaging; 2010 May; 37(5):849-50. PubMed ID: 20306031
[No Abstract] [Full Text] [Related]
2. Potential and pitfalls of therapy with alpha-particles.
Welch MJ
J Nucl Med; 2005 Aug; 46(8):1254-5. PubMed ID: 16085579
[No Abstract] [Full Text] [Related]
3. Can α-radioimmunotherapy increase efficacy for the systemic control of cancer?
Allen BJ
Immunotherapy; 2011 Apr; 3(4):455-8. PubMed ID: 21463184
[No Abstract] [Full Text] [Related]
4. [Alpha-Radioimmunotherapy: principle and relevance in anti-tumor immunity].
Ménager J; Gorin JB; Fichou N; Gouard S; Morgenstern A; Bruchertseifer F; Davodeau F; Kraeber-Bodéré F; Chérel M; Gaschet J; Guilloux Y
Med Sci (Paris); 2016 Apr; 32(4):362-9. PubMed ID: 27137693
[TBL] [Abstract][Full Text] [Related]
5. The best radionuclide for radioimmunotherapy of small tumors: beta- or alpha-emitter?
Barbet J; Chatal JF
Eur J Nucl Med Mol Imaging; 2011 Feb; 38(2):271-3. PubMed ID: 21161707
[No Abstract] [Full Text] [Related]
6. [Alpha-radioimmunotherapy: a review of recent developments].
Supiot S; Thillays F; Rio E; Mahé MA; Barbet FJ; Kraeber-Bodéré F; Chérel M
Cancer Radiother; 2007 Sep; 11(5):252-9. PubMed ID: 17604673
[TBL] [Abstract][Full Text] [Related]
7. Two approaches for enhancing radioimmunotherapy: alpha emitters and hyperthermia.
Zalutsky MR; Schuster JM; Garg PK; Archer GE; Dewhirst MW; Bigner DD
Recent Results Cancer Res; 1996; 141():101-22. PubMed ID: 8722422
[No Abstract] [Full Text] [Related]
8. Radionuclide antibody-conjugates, a targeted therapy towards cancer.
Kitson SL; Cuccurullo V; Moody TS; Mansi L
Curr Radiopharm; 2013 Jun; 6(2):57-71. PubMed ID: 23808764
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunotherapy with alpha-particle emitting radionuclides.
Zalutsky MR; Pozzi OR
Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
[TBL] [Abstract][Full Text] [Related]
10. A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies.
Wong JY; Chu DZ; Williams LE; Liu A; Zhan J; Yamauchi DM; Wilczynski S; Wu AM; Yazaki PJ; Shively JE; Leong L; Raubitschek AA
Cancer Biother Radiopharm; 2006 Apr; 21(2):88-100. PubMed ID: 16706629
[TBL] [Abstract][Full Text] [Related]
11. Targeted alpha-particle therapy of microscopic disease: Providing a further rationale for clinical investigation.
Zalutsky MR
J Nucl Med; 2006 Aug; 47(8):1238-40. PubMed ID: 16882999
[No Abstract] [Full Text] [Related]
12. New developments in monoclonal antibodies for cancer detection and therapy.
Goldenberg DM
CA Cancer J Clin; 1994; 44(1):43-64. PubMed ID: 8281471
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunotherapy with α-particle-emitting radionuclides.
Seidl C
Immunotherapy; 2014; 6(4):431-58. PubMed ID: 24815783
[TBL] [Abstract][Full Text] [Related]
14. Alpha radioimmunotherapy using
Cheal SM; McDevitt MR; Santich BH; Patel M; Yang G; Fung EK; Veach DR; Bell M; Ahad A; Vargas DB; Punzalan B; Pillarsetty NVK; Xu H; Guo HF; Monette S; Michel AO; Piersigilli A; Scheinberg DA; Ouerfelli O; Cheung NV; Larson SM
Theranostics; 2020; 10(25):11359-11375. PubMed ID: 33052220
[TBL] [Abstract][Full Text] [Related]
15. Alpha-particle radioimmunotherapy with astatine-211 and bismuth-213.
Lucignani G
Eur J Nucl Med Mol Imaging; 2008 Sep; 35(9):1729-33. PubMed ID: 18542953
[No Abstract] [Full Text] [Related]
16. Radioimmunotherapy of human tumours.
Larson SM; Carrasquillo JA; Cheung NK; Press OW
Nat Rev Cancer; 2015 Jun; 15(6):347-60. PubMed ID: 25998714
[TBL] [Abstract][Full Text] [Related]
17. An Overview of Targeted Alpha Therapy with
Morgenstern A; Apostolidis C; Kratochwil C; Sathekge M; Krolicki L; Bruchertseifer F
Curr Radiopharm; 2018; 11(3):200-208. PubMed ID: 29732998
[TBL] [Abstract][Full Text] [Related]
18. [9th Symposium on Targeted Alpha Therapy].
Kaku Igaku; 2015 Nov; 52(4):367-8. PubMed ID: 27263271
[No Abstract] [Full Text] [Related]
19. Alpha particle therapy poised to become new line of cancer treatment.
Kotz D
J Nucl Med; 1998 Feb; 39(2):17N-19N, 36N. PubMed ID: 9476918
[No Abstract] [Full Text] [Related]
20. Model of Intraperitoneal Targeted α-Particle Therapy Shows That Posttherapy Cold-Antibody Boost Enhances Microtumor Radiation Dose and Treatable Tumor Sizes.
Palm S; Bäck T; Lindegren S; Hultborn R; Jacobsson L; Albertsson P
J Nucl Med; 2018 Apr; 59(4):646-651. PubMed ID: 29175984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
